Cervical Cancer Trials
Select Clinical Trial
Protocol Number: Regeneron R2810-ONC-1676/GOG 3016 (CVP 1601)
Protocol Title: An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator's Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma
Eligibility: Women, ages 18 or older, with progression or recurrence of cervical cancer
Contact Information: (910) 715-2200
____________________________________________________________________________________________